Colorado lawmakers are advancing legislation aimed at protecting consumers from potentially harmful and misleading weight loss products, specifically those marketed as compounded medications. The bill, Senate Bill 26-066, seeks to increase oversight of these custom-made drugs, which have seen a surge in popularity alongside newer GLP-1 receptor agonists like Ozempic and Wegovy.
The growing demand for weight loss solutions, coupled with the high cost of brand-name medications, has created a market for compounded alternatives. However, concerns are rising about the safety and efficacy of these products, as they are not subject to the same rigorous FDA approval process as traditional pharmaceuticals. Spending on GLP-1 medications, a class of drugs used for weight management and diabetes, increased by more than 500 percent between 2018 and 2023, according to the American Medical Association according to a recent report.
The proposed legislation doesn’t target established brands like Ozempic and Wegovy. Instead, it focuses on regulating the compounding of GLP-1 medications, ensuring that these custom-made drugs meet certain safety standards. Specifically, the bill requires that compounded weight loss medications either receive FDA approval or utilize ingredients sourced from facilities inspected by the FDA. Accurate labeling of ingredients and their origin is also mandated.
Addressing Concerns About Misleading Products
Senator John Carson (R-CO-30) explained that the bill was prompted by the proliferation of questionable products being marketed online. “I’ve gotten solicitations, for example, online of medications that will say get your Ozempic for $29 a month or whatever,” Carson said. “When you actually click on it, go in there, it’s not Ozempic at all. It’s some other product, which, the ones I’ve seen, they do say it’s not FDA reviewed or approved.” This practice raises concerns about the potential for ineffective or even dangerous substances being sold to unsuspecting consumers.
The bill aims to provide greater transparency and accountability in the compounding industry, ensuring that individuals seeking weight loss treatments receive safe and accurately labeled products. It would empower the Colorado attorney general’s office to enforce the regulations as a deceptive trade practice under the Colorado Consumer Protection Act.
Exemptions and Next Steps
The legislation includes specific exemptions to avoid unintended consequences. Hospitals and long-term care facilities will not be subject to the new rules, and the bill explicitly states that it will not interfere with individual doctor-patient relationships. “We don’t interfere with an individual doctor-patient relationship,” Carson emphasized. “If the doctor is prescribing a particular weight loss treatment, this bill is not going to say you can’t do that.”
Having already passed through a Senate committee, SB26-066 is scheduled for consideration by the full Senate floor on Monday. If passed and signed into law, the bill is expected to bolster consumer confidence in the quality and safety of GLP-1 products available in Colorado. Carson believes the legislation will “improve just the confidence of people that when they’re buying GLP-1 products, that they’re going to get a good quality and a safe product, and they’re going to be informed on what the ingredients are, and they’re going to recognize that it’s not some knockoff product.”
Colorado recently reversed course and will continue to cover the cost of weight-loss drugs like Wegovy for state employees, as reported by The Colorado Sun, demonstrating a complex landscape of policy decisions surrounding access to these medications.
Disclaimer: This article provides informational content and should not be considered medical advice. Please consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on the regulation of compounded medications? Share your comments below, and please share this article with anyone who might locate it helpful.
